|
Re: Contest
|
7
|
Resverlogix Corp.
|
Sep 16, 2019 12:35PM
|
|
Re: Shorts
|
3
|
Resverlogix Corp.
|
Aug 15, 2019 02:35PM
|
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
8
|
Resverlogix Corp.
|
Aug 08, 2019 02:15PM
|
|
Re: Sedar filings - Loan balance
|
5
|
Resverlogix Corp.
|
Jul 29, 2019 10:20PM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
6
|
Resverlogix Corp.
|
Jul 03, 2019 12:19PM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
3
|
Resverlogix Corp.
|
Jul 02, 2019 12:50PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 11:30AM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
3
|
Resverlogix Corp.
|
Jun 14, 2019 11:23AM
|
|
Re: PAH Plans get a write up in Pulmonary Hypertension News
|
8
|
Resverlogix Corp.
|
May 21, 2019 01:15PM
|
|
Re: What we know and what we don't.....
|
3
|
Resverlogix Corp.
|
May 16, 2019 11:06PM
|
|
Re: What we know and what we don't.....
|
4
|
Resverlogix Corp.
|
May 16, 2019 05:00PM
|
|
Re: What we know and what we don't.....
|
6
|
Resverlogix Corp.
|
May 16, 2019 04:49PM
|
|
Re: Not much happening these days regarding share price
|
4
|
Resverlogix Corp.
|
Apr 10, 2019 02:41PM
|
|
Re: No mention of efficacy again...
|
5
|
Resverlogix Corp.
|
Mar 27, 2019 01:44PM
|
|
Re: AAC Poster Question on MoCA
|
8
|
Resverlogix Corp.
|
Mar 21, 2019 07:43PM
|
|
Re: ACC 2019 Abstracts
|
4
|
Resverlogix Corp.
|
Mar 19, 2019 07:31PM
|
|
Re: ACC 2019 Abstracts
|
4
|
Resverlogix Corp.
|
Mar 19, 2019 03:24PM
|
|
Re: ACC 2019 Abstracts
|
4
|
Resverlogix Corp.
|
Mar 19, 2019 02:36PM
|
|
Re: Top Line Mid Year
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 03:38PM
|
|
Re: Top Line Mid Year
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 03:00PM
|
